SXTC logo

CHINA SXT PHARMACEUTICALS-A

SXTCNASDAQ
๐Ÿ† #4324 by market capUS Equity
$3.51โ–ผ $0.08 (โˆ’2.23%)
๐ŸŒ™ After hours$3.41โ–ผ 2.85%Regular close ยท extended-hours price shown
1hโ€”
24hโ–ผ 2.2%
7dโ–ผ 34.7%
14dโ–ผ 15.3%
30dโ–ผ 98.3%
1yโ–ผ 100.0%
๐ŸฆMarket Cap
$150M
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
-34.6%
Declining
๐Ÿ“ŠGross Margin
21.9%
Moderate
๐Ÿ’ตFCF Margin
36.9%
Strong
โš–๏ธP/S Ratio
103.0x
Expensive
Otter Score
56
Weak

Trading Snapshot

Day Range
$3.46 โ€“ $3.56
52-Week Range
$3.15 โ€“ $83,758.40
Volume
$2.81B
Avg Volume
$1.91B
Shares Outstanding
42.7M
Next Earnings
Oct 15, 2026

Fundamentals Snapshot

Annual Revenue
$1M
Last Q Revenue
$1M
P/E Ratio
โ€”
P/S Ratio
103.0x
EPS (TTM)
$-7.95
Dividend Yield
โ€”

Why Investors Own SXTC

  • โœ“High-growth profile โ€” revenue up +34.0% YoY with expanding US Equity exposure.
  • โœ“Healthy economics โ€” 74% gross margin and 16% free-cash-flow margin.
  • โœ“New products and segments could unlock additional revenue streams.
โš ๏ธ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$1Mโ–ฒ +32.0% YoY
Gross Margin (TTM)
73.9%โ–ฒ +3.8% YoY
Operating Income (TTM)
$115,844โ–ฒ +32.0% YoY
Free Cash Flow (TTM)
$172,694โ–ฒ +32.0% YoY

About CHINA SXT PHARMACEUTICALS-A

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.

๐Ÿฆฆ

Otter Score Breakdown

โ“˜
๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
โšกMomentumโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Weak
56/100

Analyst Price Target

โ“˜
Average Target
$4.49
โ–ฒ +27.8% Upside
High Target$5.36
Low Target$4.13
Based on 22 analysts

Latest News & Updates